Harnessing benefit from targeting tumor associated carbohydrate antigens
Integrating additive or synergistic antitumor effects that focus on distinct elements of tumor biology are the most rational strategies for cancer treatment. Treatments for breast cancer have increased overall survival, but remain limited by lack of efficacy in a subset of breast cancer patients. Th...
Saved in:
Main Authors: | Thomas Kieber-Emmons (Author), Behjatolah Monzavi-Karbassi (Author), Laura F. Hutchins (Author), Angela Pennisi (Author), Issam Makhoul (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Harnessing the Benefits of Telehealth in Long COVID Service Provision
by: Naomi Whyler, et al.
Published: (2024) -
Harnessing the Benefits of Endogenous Hydrogen Sulfide to Reduce Cardiovascular Disease
by: Kevin M. Casin, et al.
Published: (2021) -
Chimeric antigen receptor (CAR) T-cell therapy: Harnessing extracellular vesicles for enhanced efficacy
by: Beatrice Spokeviciute, et al.
Published: (2024) -
Harnessing MerTK agonism for targeted therapeutics
by: Vivekananda Kedage, et al.
Published: (2020) -
Harnessing Biomaterials for Safeguarding Chimeric Antigen Receptor T Cell Therapy: An Artful Expedition in Mitigating Adverse Effects
by: Zhaozhao Chen, et al.
Published: (2024)